Opicapone in Parkinson’s disease: a real-world, multicenter, retrospective study to identify patient characteristics for sustained treatment benefit
Clelia Pellicano(Fondazione Santa Lucia), Tommaso Schirinzi(University of Rome Tor Vergata), Mariangela Pierantozzi(University of Rome Tor Vergata), Nicola Modugno(Istituto Neurologico Mediterraneo), Matteo Costanzo, Maria Ilenia De Bartolo(Istituto Neurologico Mediterraneo), Roberta Bovenzi(University of Rome Tor Vergata), Giovanni Fabbrini(Istituto Neurologico Mediterraneo), Alessandro Stefani(University of Rome Tor Vergata), Francesca Sommaruga(Fondazione Santa Lucia), Daniele Belvisi(Marche Polytechnic University), Jessica Blandino(Fondazione Santa Lucia), Fabrizio Piras(Fondazione Santa Lucia)
Cited by 2
Related Papers
ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries
|Translational Psychiatry|2020|702
Distinct Subcortical Volume Alterations in Pediatric and Adult OCD: A Worldwide Meta- and Mega-Analysis
|American Journal of Psychiatry|2016|348